Loading...
UK Trademark — IPO
UK00918052091
Application UK00918052091 · Registered
Quick Facts
| Application Number | UK00918052091 |
| Status | Registered |
| Owner | PAIGE.AI, Inc. |
| Filed | 2019-04-16 |
| Registered | 2019-09-12 |
| Renewal Due | 2029-04-16 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Is this trademark active?
Yes. UK00918052091 is currently a registered UK trademark, with renewal due on 2029-04-16. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 9 — Electrical & IT
Software, namely, computer programs for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software for use in evaluation of prognosis relating to diseases, states, or conditions; software for use in monitoring of diseases, states, or conditions; software for use to detect or identify predispositions to diseases, states, or conditions; software for use to detect or determine the recurrence of diseases, states, or conditions; software for use to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software for use in clinical management of diseases, states, or conditions; software for use in the selection of treatment for diseases, states, or conditions; software for use in prevention of diseases, states, or conditions, namely, software that reviews and analyzes clinical pathology slides, and identifies measures to prevent future disease development; software for use in palliation or treatment of diseases, states or conditions; software for use in research or development in the field of life sciences; software for use in research or development in the field of medicine; software for use in research or development in the field of healthcare; software for use in research or development in the field of cancer; software for use in research or development in the field of oncology; software for use in research or development in the field of pathology.
Class 42 — Scientific & IT Services
Software as a service (SaaS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services featuring software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services featuring software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes.
Class 44 — Medical & Beauty Services
Medical services; cancer therapy services; medical testing, namely, the review and analysis of patients' clinical slides to identify additional recommended medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; providing non-research related medical information via the internet; medical analysis services for the diagnosis of cancer by reviewing pathological samples on slides.
Device Elements (Vienna Classification)
This figurative mark is indexed under the following Vienna categories by the UK IPO:
- 02.03.01 — Human beings
- 16.03.15 — Telecommunications, sound recording or reproduction, computers, photography, cinematography, optics
Timeline
- Filed: 2019-04-16
- Registered: 2019-09-12
- Renewal due: 2029-04-16
About This Trademark
This device mark (application number UK00918052091) is a registered trademark on the UK IPO register, filed by PAIGE.AI, Inc. on 16 April 2019, with registration granted on 12 September 2019. It is due to expire on 16 April 2029.
This mark is recorded under multiple classes: Class 9 (scientific, electrical & IT apparatus); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Page, White & Farrer Limited.
Frequently Asked Questions
Is UK trademark UK00918052091 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00918052091 as registered.
Which Nice classes is UK trademark UK00918052091 registered under?
UK trademark UK00918052091 is recorded in Class 9 (scientific, electrical & IT apparatus); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 9: Software, namely, computer programs for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software for use in evaluation of prognosi…
When was UK trademark UK00918052091 filed?
UK trademark UK00918052091 was filed at the UK IPO on 16 April 2019 and registered on 12 September 2019.
When does UK trademark UK00918052091 need to be renewed?
UK trademark UK00918052091 is currently recorded as valid until 16 April 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00918052091?
Page, White & Farrer Limited is listed as the attorney / representative of record for UK trademark UK00918052091 on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.